![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.553, 2008-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Blood glucose self monitoring not economical in T2DM
Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Self-monitoring for T2DM in Canada: what do the models say?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Self-monitoring of blood glucose not worth it in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 597, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :